Follow this preprint

Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system

Qi Wei, Prof Philip J. Mease, Michael Chiorean, Lulu Iles-Shih, Wanessa F. Matos, Andrew Baumgartner, Sevda Molani, Yeon Mi Hwang, Basazin Belhu, Alexandra Ralevski, Jennifer Hadlock
doi: https://doi.org/10.1101/2023.06.26.23291904
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2023.06.26.23291904
History 
  • June 28, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Qi Wei, PhDa,∗,
  2. Prof Philip J. Mease, MDb,∗,
  3. Michael Chiorean, MDc,
  4. Lulu Iles-Shih, MDc,
  5. Wanessa F. Matos, MDa,
  6. Andrew Baumgartner, PhDa,
  7. Sevda Molani, PhDa,
  8. Yeon Mi Hwang, Msca,
  9. Basazin Belhu, Bsca,
  10. Alexandra Ralevski, PhDa and
  11. Jennifer Hadlock, MDa,d,∗∗
  1. aInstitute for Systems Biology, Seattle, WA, USA
  2. bProvidence St. Joseph Health/ Swedish Medical Center, Rheumatology, Seattle, WA, USA
  3. cDigestive Health Institute, Swedish Medical Center, Seattle, WA, USA
  4. dUniversity of Washington, Biomedical Informatics and Medical Education, Seattle, WA, USA
  1. ↵∗∗Corresponding author; email: jhadlock{at}systemsbiology.org

  1. ↵∗ Authors contributed equally

  2. Preprint submitted to The Lancet

  3. October 31, 2022

Back to top
Posted June 28, 2023.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system
Qi Wei, Prof Philip J. Mease, Michael Chiorean, Lulu Iles-Shih, Wanessa F. Matos, Andrew Baumgartner, Sevda Molani, Yeon Mi Hwang, Basazin Belhu, Alexandra Ralevski, Jennifer Hadlock
medRxiv 2023.06.26.23291904; doi: https://doi.org/10.1101/2023.06.26.23291904
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.